NCT02285816 2026-03-09
MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1/2 Active not recruiting
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Children's Oncology Group
Children's Oncology Group